Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02479451 · ClinicalTrials.gov registry record · Phase 2
Helping Olfaction and Nutrition On Renal Replacement
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT02479451: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT02479451 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 7 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02479451, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This clinical trial examines whether nasal theophylline administration can improve olfaction and nutrition in hemodialysis patients.
Primary Outcome
Smell identification test is a validated 40-item scratch and sniff smell identification test that was administered by study investigators. Scores on this test scale range between 0 (minimum) to 40 (maximum). Higher score indicates better ability for smell identification. Total scores are reported on this scale (no sub-scales). The unit is score on this scale.
Interventions
- DRUG Theophylline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-10 |
| Est. Completion | 2022-07 |
| Phase | Phase 2 |
What the finished NCT02479451 record still lists
NCT02479451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Theophylline is the first listed.
NCT02479451 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02479451 about?
NCT02479451 is a clinical study titled "Helping Olfaction and Nutrition On Renal Replacement". This clinical trial examines whether nasal theophylline administration can improve olfaction and nutrition in hemodialysis patients.
What is the current status of trial NCT02479451?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2015-10. Estimated completion is 2022-07.
What interventions are being tested in trial NCT02479451?
The interventions under investigation include: Theophylline (DRUG).
Who is sponsoring clinical trial NCT02479451?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02479451's enrollment target sits among peer trials
7 1996th of 2000 higher than 5 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia